Jim Simons Htg Molecular Diagnostics, Inc Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.62 - $1.89 $41,934 - $127,832	-67,636 Reduced 43.91%	86,402 $53,000
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.45 $45,320 - $142,856	98,522 Added 177.47%	154,038 $159,000
Q1 2022 May 13, 2022	BUY	$1.39 - $5.51 $1,251 - $4,959	900 Added 1.65%	55,516 $77,000
Q4 2021 Feb 11, 2022	SELL	$3.23 - $5.97 $4,199 - $7,761	-1,300 Reduced 2.32%	54,616 $296,000
Q3 2021 Nov 12, 2021	SELL	$5.01 - $6.8 $6,012 - $8,160	-1,200 Reduced 2.1%	55,916 $319,000
Q2 2021 Aug 13, 2021	SELL	$3.52 - $5.98 $287,474 - $488,380	-81,669 Reduced 58.85%	57,116 $332,000
Q1 2021 May 13, 2021	BUY	$4.99 - $7.83 $215,413 - $338,013	43,169 Added 45.15%	138,785 $759,000
Q4 2020 Feb 10, 2021	BUY	$4.14 - $5.95 $395,850 - $568,915	95,616 New	95,616 $458,000

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.